August 17, 2021
STELLAPHARM was born to care and protect patient’s health, to help enhancing their lives and living longer. Your health, for today and for future.
For over 50 years, warfarin has been the drug of choice in preventing AF-related strokes, but a new type of anticoagulant offers more options.
What is an anticoagulant medicine?
An anticoagulant medicine makes the blood take longer to clot. It plays a vital part in helping to prevent strokes specifically caused by atrial fibrillation (AF).
AF increases the risk of stroke as it can lead to blood pooling in the heart, which increases the risk of clots forming. If these clots are ejected by the heart, they can block a blood vessel in the brain and cause a stroke.
Warfarin is the most commonly prescribed anticoagulant and, when used appropriately, it’s an effective way of significantly reducing the risk of AF-related strokes. But it requires frequent blood tests and careful monitoring.
What are NOACs and who are they recommended for?
The novel oral anticoagulants (NOACs) are a new class of anticoagulant drug. They can be used in the prevention of stroke for people with non-valvular AF, which is when AF is not associated with a problem in a heart valve. They can also be used in the management of venous thromboembolism, which is when a blood clot forms in a vein. NOACs can help to prevent clots from forming in the first place and help protect you from certain types of stroke.
How many different NOACs are there?
Types of NOAC:
How do they work?
NOACs interrupt part of the complex system involved in the formation of blood clots. This causes the blood to take longer to clot and reduces the risk of AF-related stroke. All of the NOACs have been shown to be as effective at preventing strokes as warfarin. The main difference between NOACs and warfarin is that NOACs are less influenced by diet and other medications.
This means a set dose of a NOAC can be prescribed and the doctor will know that the patient is protected against stroke as long as the drug is taken. In practical terms, this means that the patient does not need to have blood tests to check whether it is working.
Does this mean everyone with AF who is taking warfarin should swap to a NOAC?
No, warfarin is very effective at preventing strokes, and if you’re well controlled on warfarin and are without side effects, then there is no real gain in swapping to a NOAC.
What are the potential side effects?
The side effects depend on exactly which NOAC is being taken; for example, dabigatran can cause stomach upset. As with all anticoagulants, however, a serious complication that can happen is having a major bleed. It’s uncommon, and the chance of having a major bleed with a NOAC is either the same or less than it is if you are taking warfarin. There are several reversal agents available for someone taking warfarin and there is now a reversal agent available for dabigatran (which is for emergency hospital use only). The other NOACs currently have no reversal agent.
The treatment for a bleed will depend on where you are bleeding from and the extent of it. Some signs and symptoms of unusual bleeding can include unexpected bleeding or bleeding that lasts a long time; severe or unexplained bruising, or bruising that gets bigger without a cause; and red or black (tar-like) bowel motions.
You should call your doctor if you have any signs or symptoms of unusual bleeding. If there are signs of internal bleeding or the bleeding is severe, then call medical emergency number.
The anticoagulant effect of NOACs fades rapidly, around 12 – 24 hours after the last dose.
If you are taking anticoagulant medicine and you suffer a head injury, such as falling and hitting your head, or experience a blow to the head, seek medical help without delay to rule out internal bleeding which may not be immediately obvious.
What happens if you forget to take a dose?
It’s essential that NOACs are taken every day. This is because they act for a much shorter period of time than warfarin, so if you miss a dose, you’re not protected. If you’ve forgotten a dose and it is less than half the time to the next scheduled dose of the drug, take the medicine and continue as normal. If not, take the next dose at the scheduled time. It is important not to take a double dose of the medicine, as that could increase the risk of bleeding.
Are there people for whom NOACs are unsuitable?
If a person has a high risk of bleeding, then oral anticoagulation, including NOACs and warfarin, may not be recommended. There is not enough information about the effects of NOACs in people who take an anticoagulant because they have a metallic heart valve, so it’s not recommended for this group. If you have moderate kidney impairment, NOACs may also not be recommended, as you could be more likely to have a bleed. Your doctor will be able to advise you of what the best option is for you.
Are there any obstacles to them being prescribed?
The main obstacle is that NOACs are more expensive than warfarin, even when the frequent blood testing associated with warfarin is taken into account. Doctors may be less familiar with NOACs, as they have been prescribing warfarin for decades, compared with only a few years for NOACs. With time, NOACs will reduce in price and more doctors will be comfortable prescribing them.
Source: British Heart Foundation
Stellapharm is one of leading generics pharmaceutical companies and strong producer of anti-viral drugs in Vietnam. The company established in Vietnam in 2000; and focuses on both prescription drugs and non-prescription especially in cardiovascular diseases, antiviral drugs, anti-diabetics drugs, etc. and our products are now used by millions of patients in more than 50 countries worldwide.
The company is globally recognized for its quality through our facilities have been audited and approved by stringent authority like EMA, PMDA, Taiwan GMP, local WHO and others.
Additional information for this article: Stellapharm J.V. Co., Ltd. – Branch 1
A: 40 Tu Do Avenue, Vietnam – Singapore Industrial Park, An Phu Ward, Thuan An City, Binh Duong Province, Vietnam
T: +84 274 376 7470 | F: +84 274 376 7469 | E: firstname.lastname@example.org | W: www.stellapharm.com
Theo tuổi tác, hệ miễn dịch của chúng ta trở nên kém hiệu quả hơn trong việc đối phó với các tình trạng nhiễm trùng cũng như kém đáp ứng với việc chủng ngừa. Đồng thời, hệ miễn dịch lão hóa có mối liên hệ với tình trạng viêm mạn tính, từ đó làm tăng
With age, the human immune system becomes less effective at tackling infections and less responsive to vaccinations. At the same time, the aging immune system is associated with chronic inflammation, which increases the risk of almost all conditions linked to old age. The good news is that exercising and adopting the right diet may help